Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
B-Cell Chronic Lymphocytic Leukemia
100%
Venetoclax
82%
Germinoma
54%
Minimal Residual Disease
50%
Neoplasm
44%
Germ Cell
43%
Ibrutinib
35%
Carcinoma in Situ
30%
Obinutuzumab
28%
Testes
27%
Seminoma
26%
Gonadoblastoma
25%
Gene Mutation
24%
Induced Pluripotent Stem Cell
22%
Rituximab
22%
Keyphrases
Chronic Lymphocytic Leukemia
68%
Venetoclax
60%
Fixation Duration
35%
Minimal Residual Disease
34%
Obinutuzumab
28%
Phase II Trial
22%
Ibrutinib
22%
Relapsed or Refractory
13%
Complete Remission
13%
Fludarabine
12%
High Risk
12%
Endpoint Analysis
12%
Previously Untreated
12%
Germ Cell Tumor
11%
GFI1B
11%
Biochemistry, Genetics and Molecular Biology
Germ Cell
55%
Induced Pluripotent Stem Cell
33%
Karyotype
29%
Down Syndrome
22%
Megakaryoblast
22%
DNA Methylation
16%
Gene Mutation
16%
Methylation
13%
Morphology
12%
Human Induced Pluripotent Stem Cell
11%
Proband
11%
PRRT2
11%
Trisomy
11%
Platelet
11%
Derivative Chromosome
11%